March 12, 2024 PBIRx is is excited to announce the launch of its new video series, PBIRx Success Stories. These client testimonial videos highlight the successful partnerships between PBIRx and its valued client partners. In this insightful series, clients share their experiences working with PBIRx's team of skilled account consultants, PharmDs, and analysts to achieve substantial plan cost savings, reduce drug trends, and enhance member outcomes and satisfaction.

December 19, 2023 PBIRx is proud to mark its 30th anniversary as the premier pharmacy benefit auditing and consulting firm with a year of record-setting growth and a continued 99% client retention rate. Growth in 2023 extended to a significant investment in technology, the cornerstone of PBIRx’s data-driven solutions, outpacing the evolution of the ever-changing pharmacy benefit landscape. PBIRx also augmented its personnel with hiring growth in nearly all sectors.

New developments in the ever-evolving GLP-1 market. Novo Nordisk announced that it will cut U.S. list prices for Wegovy (for weight loss) and Ozempic (for diabetes) by up to 50% starting January 1, 2027. Both products will list for...